Zhou Xiaowen, Xiao Zhenxu, Wu Wanqing, Chen Yuntao, Yuan Changzheng, Leng Yue, Yao Yao, Zhao Qianhua, Hofman Albert, Brunner Eric, Ding Ding
Institute of Neurology, National Clinical Research Center for Aging and Medicine, National Center for Neurological Disorders, Huashan Hospital, Fudan University, Shanghai, China.
Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.
Lancet Reg Health West Pac. 2025 Jan 21;55:101465. doi: 10.1016/j.lanwpc.2025.101465. eCollection 2025 Feb.
China accounts for 1/5 of the global population and China faces a particularly heavy dementia burden due to its rapidly ageing population. Unique historical events, genetic background, sociocultural factors, lifestyle, and the COVID-19 pandemic further influence cognitive outcomes in the Chinese population. We searched PubMed, Web of Science, and Embase for community-based cohort studies related to dementia in the Chinese population, and summarized the characteristics, methodologies, and major findings published over the last 25 years from 39 cohorts. We identified critical research gaps and propose future directions, including enhancing sample representativeness, investigating China-specific risk factors, expanding exposure measurements to the whole life-span, collecting objective data, conducting administer-friendly domain-specific cognitive assessments, adopting pathological diagnostic criteria, standardizing biobank construction, verifying multi-modal biomarkers, examining social and genetic-environmental aspects, and monitoring post-COVID cognitive health, to approach high quality of dementia studies that can provide solid evidence to policy making and promote global brain health research.
中国人口占全球人口的五分之一,由于人口迅速老龄化,中国面临着尤为沉重的痴呆症负担。独特的历史事件、遗传背景、社会文化因素、生活方式以及新冠疫情进一步影响了中国人群的认知结果。我们在PubMed、科学网和Embase上检索了与中国人群痴呆症相关的基于社区的队列研究,并总结了过去25年中39个队列的特征、方法和主要研究结果。我们确定了关键的研究差距并提出了未来的方向,包括提高样本代表性、研究中国特有的风险因素、将暴露测量扩展到整个生命周期、收集客观数据、进行便于管理的特定领域认知评估、采用病理诊断标准、规范生物样本库建设、验证多模态生物标志物、研究社会和基因-环境方面以及监测新冠疫情后的认知健康,以实现高质量的痴呆症研究,为政策制定提供坚实证据并促进全球脑健康研究。